Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

https://www.soho2020.com/

Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
Events

Playback speed

10 seconds

2020 SOHO CP-CML Update: How Effective Is 50mg Daily Dasatinib in Newly Diagnosed Disease? Is Asciminib Superior to Bosutinib? Does Gradual TKI Dose Reduction Improve TFR Rates?

By Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020) FEATURING Michael Deininger

0 views

October 30, 2020

SOHO 2020 on-demand content is available through January 12, 2021. To access the virtual environment, ...
read more ↘ resources and on-demand webinars, go to https://soho.click/register.
↖ read less

Comments 0

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Leukemia